Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1709069 | 0.86 | MAPT (0.36) | L3MBTL1 | |
| SCHEMBL13966972 | 0.82 | MAPT (0.37) | L3MBTL1 | |
| SCHEMBL31551165 | 0.79 | MEN1 (0.34) | L3MBTL1 | |
| SCHEMBL14089210 | 0.72 | MEN1 (0.33) | — | |
| SCHEMBL1709074 | 0.71 | FOLH1 (0.32) | — | |
| SCHEMBL13966973 | 0.69 | MAPT (0.52) | L3MBTL1 | |
| SCHEMBL10068624 | 0.69 | MEN1 (0.46) | L3MBTL1 | |
| SCHEMBL10035959 | 0.69 | MEN1 (0.46) | L3MBTL1 | |
| SCHEMBL2410627 | 0.69 | MEN1 (0.46) | L3MBTL1 | |
| SCHEMBL12364496 | 0.69 | MEN1 (0.46) | L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012048063-A2 | CYANINE COMPOUNDS, CONJUGATES AND METHOD OF USE | EMD MILLIPORE CORPORATION (US) | 2012-04-12 | — | — | WO | disclosed |
| US-20120088262-A1 | CYANINE COMPOUNDS, CONJUGATES AND METHOD OF USE | MILLIPORE CORPORATION (US) | 2012-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120088262-A1 | CYANINE COMPOUNDS, CONJUGATES AND METHOD OF USE | CASP7, MCL1, CARS1 | L3MBTL1 889/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.